Navigation Links
Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award
Date:9/29/2010

AUSTIN, Texas, Sept. 29 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), today announced it has won the prestigious 2010 Prix Galien USA Award for its innovative xTAG® Respiratory Viral Panel (RVP). The novel diagnostic test was named Best Medical Technology at the Prix Galien USA and International awards ceremony and gala held September 28, 2010, at the American Museum of Natural History in New York City.

(Logo:  http://photos.prnewswire.com/prnh/20100929/DA73442LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100929/DA73442LOGO)

(Logo:  http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100104/LUMINEXLOGO)

"We are very pleased and excited to receive this coveted award, which recognizes Luminex's xTAG Respiratory Viral Panel and its important contributions to healthcare," said Patrick Balthrop, President and Chief Executive Officer of Luminex. "xTAG RVP is helping physicians pinpoint the cause of respiratory infections faster and more accurately than ever before. The test is improving patient care, preventing the use of unnecessary medications and reducing healthcare costs.  We are honored to be recognized by Prix Galien for this product."

xTAG RVP received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in January 2008 to detect 12 viruses and subtypes that together are responsible for more than 85 percent of respiratory viral infections. The first test of its kind, it can detect more respiratory viruses than any other test on the market and provide results in a matter of hours. xTAG RVP also was an important surveillance and diagnostic tool during the 2009 Influenza A/H1N1 pandemic.  

The Prix Galien Award recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines, and is considered equivalent to the Nobel Prize. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007. The Prix Galien USA awards committee of 11 individuals includes seven Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals.

About Luminex CorporationLuminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP Technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP Technology can be obtained at www.luminexcorp.com.Luminex Corporate Contact:Harriss T. Currie, Vice President, Finance and Chief Financial Officer512.219.8020hcurrie@luminexcorp.comMatthew ScaloSr. Director of Investor Relations512.219.8020mscalo@luminexcorp.comLuminex Media Contact:Nicole Cottrill615.327.7999ncottrill@seigenthaler.com
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
2. Luminex Announces Commercial Launch of New Cystic Fibrosis Test
3. Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study
4. Luminex Corporation to Present at UBS Global Life Sciences Conference
5. Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. CEL-SCI Corporation Releases Letter to Shareholders
8. Alfacell Corporation to Present at UBS Global Life Sciences Conference
9. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
10. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
11. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , May 2, 2016  Deerfield announced ... financing of Graybug Vision, Inc. Graybug Vision is ... therapies that may transform care for ocular diseases ... Graybug Vision,s technology was first developed at Johns ... a startup venture. Graybug Vision ...
(Date:4/29/2016)... April 29, 2016  In the next ten ... shift from systems dependent on CRTs monitors to those ... modality CRT Medical monitors and will automatically sync ... host of foreseeable benefits to this technological advancement, ... modalities have to be replaced in order to ...
(Date:4/29/2016)... , April 29, 2016 ... glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years clinical ... and biotechnology industries. His last role was at Mologen ... of the Executive Board. Previously Dr. Zurlo held various ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... , ... “Engineering Bubbles,” an oil painting submitted by Canadian radiology resident Dr. ... at the Annual Meeting in Los Angeles. The first annual art forum was a ... Meeting attendees. , “Through art I hope to educate people about radiology and ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... Over $60 ... year’s best in pet gear and toys, leading product review site for Toys, Tots, ... of Excellence Awards at their Spring Showcase at the Metropolitan Pavilion in New ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... has announced a new Specialty Pharmacy Patient Satisfaction Award that will recognize specialty ... the quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled ...
(Date:5/2/2016)... ... , ... According to an American Psychological Association article, the Centers ... the age of 18. Of those who survive, many still face effects as they ... In her new book, Lyah! Lyah! Pants on Fyah!, she shares stories from women ...
(Date:5/2/2016)... ... 2016 , ... Consultative health care market research firm ... Duane Reed, VP of business development of AJMC Strategic Solutions, will be session ... General Meeting from May 15-17 at the Boca Raton Resort & Club ...
Breaking Medicine News(10 mins):